JY
NAUT icon

Jeff Yass’s Nautilus Biotechnolgy NAUT Stock Holding History

Jeff Yass’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-93,500
Closed -$259K – 12763
2023
Q1 		$259K Buy
+93,500
New +$196K ﹤0.01% 10044
2022
Q2 		– Sell
-16,000
Closed -$69K – 13579
2022
Q1 		$69K Sell
16,000
-17,400
-52% -$71.4K ﹤0.01% 12140
2021
Q4 		$173K Buy
33,400
+3,300
+11% +$17.7K ﹤0.01% 11624
2021
Q3 		$185K Buy
30,100
+5,400
+22% +$43K ﹤0.01% 11579
2021
Q2 		$249K Buy
+24,700
New +$268K ﹤0.01% 11150

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Jeff Yass's NAUT Position: Q2 2026 in Review

Jeff Yass opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 890,949 shares worth $1.67M. The stake represents ﹤0.01% of the portfolio and ranks #6903 among its holdings. This is a return to the name: Jeff Yass previously reported a position in NAUT as recently as Q4 2025.

Jeff Yass first reported a position in NAUT in Q2 2021 and has held it in 15 quarters since. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Jeff Yass held 890,949 shares of Nautilus Biotechnolgy worth $1.67M as of Q2 2026.
  • Nautilus Biotechnolgy was a new Jeff Yass position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #6903 holding.
  • Jeff Yass first reported a position in Nautilus Biotechnolgy in Q2 2021 and has held it in 15 quarters since.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.